Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ETTX

Entasis Therapeutics (ETTX)

Entasis Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETTX
DateTimeSourceHeadlineSymbolCompany
12/10/202223:30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
22/07/202207:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202207:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
12/07/202206:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
09/07/202207:05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
09/07/202207:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
09/07/202206:55Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
09/07/202206:49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202222:35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
01/07/202220:04Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202222:11Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202222:09Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202222:04Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202221:58Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ETTX